US Stock MarketDetailed Quotes

AIM AIM ImmunoTech

Watchlist
  • 0.1900
  • -0.0011-0.58%
Close Dec 20 16:00 ET
  • 0.1962
  • +0.0062+3.26%
Post 19:42 ET
12.12MMarket Cap-0.40P/E (TTM)
Full Hours
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Comments

    Trytosaveabit
    Trytosaveabit
    Dec 12 08:05
    News
    $AIM ImmunoTech (AIM.US)$ Benzinga· 2 mins ago
    AIM ImmunoTech Announced It Was Granted Patent No. 2,0832,813 Covering Ampligen For Use In Treatment Of Post-COVID Condition Of Fatigue
    Jaguar8
    Jaguar8
    Nov 27 14:33
    NEWS
    $AIM ImmunoTech (AIM.US)$
    AIM ImmunoTech Refutes Activist Group's False and Misleading Claims
    2 minutes ago, 12:30 PM PST
    Via BusinessWire
    Sets Record Straight on Mischaracterization of AIM's Historical Share Price
    Reminds AIM Shareholders of Activist Group's Numerous Lies, Omissions and Misrepresentations in Multi-Year Effort to Take Control of the Board
    Urges Shareholders to Safeguard AIM by Voting "FOR" ALL Four of the Board's Incumbent Candidates and Discarding Any Proxy Materials Receiv...
    Trytosaveabit
    Trytosaveabit
    Nov 27 14:33
    News
    $AIM ImmunoTech (AIM.US)$ AIM ImmunoTech Refutes Activist Group's False and Misleading Claims
    2 MINUTES AGO, 3:30 PM EST
    VIA BUSINESSWIRE
    Sets Record Straight on Mischaracterization of AIM's Historical Share Price
    Reminds AIM Shareholders of Activist Group's Numerous Lies, Omissions and Misrepresentations in Multi-Year Effort to Take Control of the Board
    Urges Shareholders to Safeguard AIM by Voting "FOR" ALL Four of the Board's Incumbent Candidates and Discarding Any Proxy Materials Received...
    Trytosaveabit
    Trytosaveabit
    Nov 19 07:05
    Update
    $AIM ImmunoTech (AIM.US)$ AIM ImmunoTech Announces Publication of Breast Cancer Data from Roswell Park Comprehensive Cancer Center in The Journal for ImmunoTherapy of Cancer
    4 MINUTES AGO, 8:00 AM EST
    VIA GLOBENEWSWIRE
    OCALA, Fla., Nov. 19, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company") today announced that data were published on Roswell Park Comprehensive Cancer Center's Phase 1 study evaluating AIM ImmunoTech's drug Ampligen® (also known as rintatolimod) ...
Read more
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Ermenegildo Zegna NV
ZGN
+6.16%
DexCom
DXCM
+5.57%
New Fortress Energy
NFE
+5.37%
Workday
WDAY
+2.33%
eBay
EBAY
+1.66%

Unlock the Full List